Apr 20, 2023 by James HalleyWhy Shares of Bellus Health Skyrocketed This WeekThe company has received a buyout offer from GSK.
Apr 20, 2023 by James HalleyWhy Shares of Geron Are Up 30% This WeekThe company's CEO was scheduled to speak at a virtual conference on Thursday.
Apr 19, 2023 by James HalleyWhy Shares of Legend Biotech Jumped WednesdayA leaked abstract on a phase 3 trial for the company's multiple myeloma drug Carvykti gave the stock a jolt.
Apr 18, 2023 by James Halley3 Robinhood Stocks to Buy and Hold ForeverThere are solid reasons for the trio's popularity with retail investors.
Apr 17, 2023 by James HalleyWhy Shares of Editas Medicine Rose MondayThe company is benefiting from positive news affecting other gene-editing stocks.
Apr 17, 2023 by James HalleyWhy Shares of Prometheus Biosciences Are Soaring MondayMerck's $10.8 billion buyout offer sent the clinical-stage biotech stock higher.
Apr 16, 2023 by James Halley3 Stocks You Can Keep ForeverThree solid profitable companies that are growing their businesses and their dividends.
Apr 15, 2023 by James HalleyDoes an FDA Fast Track Designation Make Regenxbio Stock a Buy Now?The company focuses on using its technology for gene-editing therapies.
Apr 14, 2023 by James HalleyWhy Shares of Brookdale Senior Living Rose This WeekThe company says it expects improved first-quarter numbers.
Apr 14, 2023 by James HalleyWhy Shares of Sana Biotechnology Jumped This WeekThe company announced details of research on two of its pre-clinical therapies.
Apr 13, 2023 by James HalleyWhy Inovio Pharmaceuticals' Shares Jumped on ThursdayThe company will present an abstract for its Ebola vaccine booster this month.
Apr 13, 2023 by James HalleyWhy Shares of CRISPR Therapeutics Jumped ThursdayAn independent drug-pricing group said that a $1.9 million cost for the company's exa-cel therapy would be cost-effective.
Apr 13, 2023 by James HalleyProceed With Caution When Considering These 5 Ultra-Popular StocksFour of these five stocks are losing money.
Apr 12, 2023 by James HalleyCould Gilead Sciences Stock Help You Become a Millionaire?The company's dominant HIV therapies and growing oncology pipeline are delivering.
Apr 11, 2023 by James HalleyWhy Shares of Shockwave Medical Jumped on TuesdayThe proposed new payment structure by the CMS would help Shockwave's business.
Apr 11, 2023 by James HalleyWhy Shares of TG Therapeutics Soared on TuesdayEarly reports of strong sales for its recently approved multiple sclerosis drug gave the stock a jolt.
Apr 11, 2023 by James HalleyWhy Shares of Adaptimmune Therapeutics Jumped TuesdayThe company bulks up its pipeline by regaining the rights to two of its clinical programs.
Apr 8, 2023 by James HalleyHere's Why Pfizer Will Bounce Back This YearThe company has used its COVID-19 therapy and vaccine profits to beef up its pipeline.
Apr 6, 2023 by James HalleyWhy BeiGene Stock Jumped ThursdayA collaboration deal helped send the Chinese biotech stock higher.
Apr 6, 2023 by James HalleyWhy Shares of Apollomics Soared in MarchThe company's shares jumped after it went public via a SPAC merger at the end of the month.
